Gestala is the latest company to emerge from China’s burgeoning brain-computer interface industry. It plans to access the ...
For additional results and analyses, including the impact of pre-training, number of training subjects, normalization effects, and other key findings, please refer to our full paper. Here, "root" ...
The Model Context Protocol just got its first official extension, and it changes what AI assistants can do. MCP Apps lets tools return interactive user interfaces—dashboards, forms, visualizations, ...
Abstract: This paper presents a real-time EEG signal processing system for detecting driver fatigue, implemented as part of a Brain-Computer Interface (BCI) application. The system leverages EEG ...
Abstract: Vigilance estimation is a critical task within the field of brain–computer interfaces, extensively applied in monitoring and optimizing user states during human–machine interaction using ...
Add Yahoo as a preferred source to see more of our stories on Google. Cancer Cell Spread and oncology or Malignant Cancerous Growth and Metastasis anatomy concept as growing tumor cells and Malignancy ...
BEIJING, Jan. 5, 2026 /PRNewswire/ -- Datasea Inc. (the "Company" or "Datasea") today announced that its China operating subsidiary, Datasea Jingwei Information Technology Co., Ltd., has entered into ...
O. Rose Broderick reports on the health policies and technologies that govern people with disabilities’ lives. Before coming to STAT, she worked at WNYC’s Radiolab and Scientific American, and her ...
Elon Musk’s Neuralink is shifting into high gear for 2026 as the company’s co-founder touts changes to the brain-computer interface devices' production. Writing on his social media platform X, Musk ...
BENGALURU, Dec 31 (Reuters) - Elon Musk's brain implant company Neuralink will start "high-volume production" of brain-computer interface devices and move to an entirely automated surgical procedure ...
Neuralink plans to begin high-volume production and fully automate surgical procedures for its brain-computer interface devices by 2026. The company, which started human trials in 2024, aims to assist ...